18.70
-0.23 (-1.22%)
| Previous Close | 18.93 |
| Open | 18.81 |
| Volume | 18,084 |
| Avg. Volume (3M) | 63,650 |
| Market Cap | 171,423,648 |
| Price / Earnings (Forward) | 123.46 |
| Price / Sales | 1.65 |
| Price / Book | 30.43 |
| 52 Weeks Range | |
| Earnings Date | 12 May 2026 |
| Profit Margin | -12.48% |
| Operating Margin (TTM) | -8.88% |
| Diluted EPS (TTM) | -1.34 |
| Quarterly Revenue Growth (YOY) | 26.40% |
| Total Debt/Equity (MRQ) | 121.96% |
| Current Ratio (MRQ) | 2.77 |
| Operating Cash Flow (TTM) | -1.80 M |
| Levered Free Cash Flow (TTM) | 1.01 M |
| Return on Assets (TTM) | -4.72% |
| Return on Equity (TTM) | -29.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | Sanara MedTech Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 0.5 |
| Average | 0.67 |
|
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 66.47% |
| % Held by Institutions | 10.43% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Stonebridge Wealth Management, Llc | 31 Mar 2026 | 136,899 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |